Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2000, p. 2880-2889, Vol. 20, No. 8
Division of Signal Transduction, Beth Israel
Deaconess Medical Center and Department of Medicine, Harvard Medical
School, Boston, Massachusetts, 02215,1 and
Department of Cell and Developmental Biology, University of
Pennsylvania School of Medicine, Philadelphia, Pennsylvania
191042
Received 15 September 1999/Returned for modification 25 October
1999/Accepted 27 January 2000
Both the Rho family of low-molecular-weight GTP-binding proteins
and protein kinases C (PKCs) mediate responses to a variety of
extracellular and intracellular signals. They share many downstream targets, including remodeling of the actin cytoskeleton, activation of
p70S6 kinase and c-jun N-terminal kinase (JNK), and
regulation of transcription and cell proliferation. We therefore
investigated whether Rho family GTP-binding proteins bind to PKCs. We
found that Cdc42 associates with atypical PKCs (aPKCs) PKC The actin cytoskeleton is dynamic,
regulation of actin polymerization is important for cell motility,
adherence, and division, and transformed cells have an altered actin
cytoskeleton, including the loss of stress fibers. The Rho family of
small GTP-binding proteins plays a central role in regulating actin
polymerization, the formation of cellular structures dependent on
actin, and transformation by some oncogenes (21).
Experiments using both constitutively active and dominant-negative
mutants of Rho family members have shown that Rac causes ruffling and
is necessary for formation of lamellipodia and cell movement
(35). Activated Rho leads to the formation of stress fibers,
and activated Cdc42 causes filopodia to form (17, 28, 34).
In addition, expression of activated forms of Rac or Cdc42 causes cells
to lose stress fibers (48). Rho family GTP-binding proteins
also stimulate other signaling pathways that are important in both
normal cellular function and transformation, including cell cycle
progression, activation of the c-jun N-terminal kinase (JNK) and p38
mitogen-activated protein (MAP) kinase pathways, and regulation of
transcription. Understanding the regulation of Rho family signaling is
important for insight into a number of cellular functions.
Most signals transmitted by Rho family members depend on the
association of effector proteins with the GTP-bound form of Rac, Rho,
or Cdc42. The first step in their activation is the catalysis of GTP
exchange for GDP by guanine nucleotide exchange factors (GEFs).
Signaling is terminated by GTPase-activating proteins (GAPs), which
stimulate GTP hydrolysis and conversion of the proteins to the
GDP-bound form. Recent efforts have focused on identifying the
immediate effector molecules that interact with the activated GTP-binding proteins. A number of direct targets have been identified, including protein serine/threonine and tyrosine kinases, a protein phosphatase, lipid kinases, and adapter proteins. Identification of the
proteins that associate with activated Rho family members has been a
fruitful approach to understanding their signaling pathways.
Protein kinases C (PKCs) regulate many of the same pathways regulated
by Rho family GTP binding proteins. The mammalian PKC family is
subdivided into conventional PKC members, comprising the PKCs and Rho family GTP-binding proteins both have effects on the actin
cytoskeleton, the activation of p70S6 kinase, the JNK
pathway, and the fos and NF- Several recent studies have directly linked PKC signaling and Rho
family signaling. The Saccharomyces cerevisiae Rho family protein Rho1p binds to PKC1, the yeast PKC homolog, and stimulates PKC1
activity in the presence of phosphatidylserine (14, 29). Rho1p-activated PKC1 initiates a MAP kinase pathway, which is crucial
to cell wall integrity. PKC The signaling pathways and targets shared by Rho family GTP-binding
proteins and PKCs led us to ask whether there is direct interaction of
PKCs with Rho family members. We found that mammalian Cdc42 associates
with aPKC Materials.
PKC isoform-specific antibodies were purchased
from Santa Cruz Biotechnology, Inc. The aPKC-specific antibody binds to
both PKC Constructs.
Flag epitope-tagged PKC Preparation and nucleotide loading of GTP-binding proteins.
GST fusion proteins of human Ras, Rac1, Cdc42, and RhoA were expressed
in bacteria and purified with glutathione-Sepharose (GSH) beads as
described previously (42). The fusion proteins were stored
in 10 mM HEPES (pH 7.5)-0.5 mM dithiothreitol (DTT) with 50% glycerol
at Association of GST fusion proteins with PKCs.
Rat brains
were finely diced and homogenized in a mixture of 50 mM HEPES (pH 7.5),
150 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.25 M
sucrose, 0.5 mM phenylmethylsulfonyl fluoride, and 1-µg/ml (each)
leupeptin, antipain, and pepstatin (1 brain per 40 ml of buffer) with a
Dounce homogenizer. The homogenate was centrifuged at
100,000 × g for 45 min. Triton X-100 was added to the
supernatant (cytosol) to a final concentration of 0.1% (wt/vol). GST
fusion proteins were loaded with nucleotide as described above and then
incubated with 1 ml of cytosol for 75 min at 4°C with constant
rocking. The beads were washed once with 1 ml of homogenization buffer
containing 0.1% (wt/vol) Triton X-100 and twice with 1 ml of HNM.
Associated proteins were resolved by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by
transfer to Immobilon-P membrane (Millipore). Membranes were blocked
with 2% (wt/vol) bovine serum albumin (BSA) in Tris-buffered saline.
The blots were probed with primary antibody and visualized with
horseradish peroxidase-conjugated secondary antibody (Boehringer Mannheim) by enhanced chemiluminescence (DuPont NEN) according to the
manufacturer's instructions.
Protein kinase assays.
Assays of PKC and p70S6
kinase activities were done as previously described (8, 27).
Cell culture and transient transfections.
Cells were grown
in Dulbecco's modified Eagles' medium (DMEM) containing 10%
(vol/vol) fetal calf serum (NIH 3T3 and COS-7 cells) or 10% (vol/vol)
heat-inactivated fetal calf serum (293 cells). The mammalian expression
vector pEBG encoding various alleles of RhoA, Rac, and Cdc42 fused to
GST has been previously described (8). COS cells were
transfected by the DEAE-dextran method. NIH 3T3 cells and 293 cells
were transfected with Lipofectamine (Gibco BRL), except for
immunofluorescence studies, in which Superfect reagent (Qiagen) was
used. In each case, the manufacturer's instructions were followed. One
or 5 µg of each DNA construct was used per 3.5- or 10-cm-diameter
plate, respectively. Cells were harvested 48 h after transfection
with the homogenization buffer described above, without sucrose,
containing 1% (wt/vol) Triton X-100. Cell lysates were incubated with
25 µl of a 50% (vol/vol) slurry of glutathione-Sepharose beads for
2 h at 4°C with constant rocking. The beads were then processed
as described in the section above.
Immunofluorescence.
NIH 3T3 cells growing on 25-mm-diameter
coverslips were transiently transfected as described above. In some
experiments, pEGFP (Clontech), which expresses green fluorescent
protein (GFP), was cotransfected and the expression of GFP was used to
identify transfected cells. Following transfection the cells were
washed with phosphate-buffered saline (PBS) and starved overnight in
serum-free DMEM. The cells were then washed with PBS before fixation
for 10 min in 3% (wt/vol) paraformaldehyde. Following three washes
with PBS, the cells were permeabilized for 4 min in PBS containing
0.2% (vol/vol) Triton X-100 and washed a further three times with PBS.
Cells were then blocked with PBS containing 1% (wt/vol) BSA for 10 min
before addition of primary antibodies diluted in blocking buffer for 1 h. The cells were washed three times with blocking buffer before the addition of secondary antibodies (conjugated to fluorophores) or
rhodamine-labeled phalloidin (100 ng/ml), diluted in blocking buffer,
for 1 h. The cells were washed three times in PBS and once in
distilled water prior to mounting of the coverslips on Fluoromont-G
mounting solution (Fisher). Images were visualized with a Nikon Diaphot
300 microscope captured on a Photometrics digital camera with Phase 3 Imaging Systems software. Stress fibers were classified as being either
present or absent in cells in cells stained with rhodamine phalloidin
and viewed by fluorescent microscopy.
GST-Cdc42 associates with aPKC in rat brain cytosol.
GST
fusions of the Rho family GTP-binding proteins RhoA, Rac1, and Cdc42
and a GST fusion protein of H-Ras were expressed in bacteria, purified
with GSH beads, and tested for their ability to associate with PKCs in
rat brain cytosol. The proteins were first loaded with GTP
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Atypical Protein Kinases C
and -
Associate
with the GTP-Binding Protein Cdc42 and Mediate Stress Fiber
Loss

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
and -
in a GTP-dependent manner. The regulatory domain of the aPKCs mediates
the interaction. Expression of activated Cdc42 results in the
translocation of PKC
from the nucleus into the cytosol, and Cdc42
and PKC
colocalize at the plasma membrane and in the cytoplasm.
Expression of activated Cdc42 leads to a loss of stress fibers, as does
overexpression of either the wild type or an activated form of PKC
.
Kinase-dead PKC
and -
constructs acted as dominant negatives and
restored stress fibers in cells expressing the activated V12 Cdc42
mutant, indicating that Cdc42-dependent loss of stress fibers requires aPKCs. Kinase-dead PKC
and -
and dominant-negative N17 Cdc42 also
blocked Ras-induced loss of stress fibers, suggesting that this pathway
may also be important for Ras-dependent cytoskeletal changes. N17 Rac
did not block Ras-induced loss of stress fibers, nor did kinase-dead
PKC
block V12 Rac-stimulated loss of stress fibers. These results
indicate that Cdc42 and Rac use different pathways to regulate stress fibers.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
,
I,
II, and
isoforms; novel PKCs comprising the
, e,
, and
forms; and atypical PKCs (aPKCs)
/
and
(26). The conventional PKCs are activated by calcium binding to the C2 domain and
diacylglycerol binding to the C1 domain. The C2 domain of the novel
PKCs does not bind calcium but they are activated by diacylglycerol.
The aPKCs have only one cysteine-rich motif in the C1 domain and do not
have a C2 domain.

promoters (44). Both PKCs
and Rho family members are necessary for cell adherence and spreading
and have effects on neurite outgrowth (20, 31, 40, 47). In
some cell types, activation of PKCs with phorbol myristate acetate
causes cells to ruffle. PKC
is necessary for formation of filopodia
and stress fibers in endothelial cells and can also phosphorylate and
activate ezrin, radixin, and moesin (30, 41).
binds to RhoA in a GTP-dependent manner
and appears to act downstream of RhoA in activation of an AP-1 promoter
in Jurkat cells (7). The activation of PKC
by interleukin
2 was blocked by Clostridium difficile toxin B, which
inhibits all Rho family members, suggesting that PKC
can be
activated by or requires Rho family members (13). The aPKCs were also shown to act downstream of Ras to mediate Ras-dependent cytoskeletal reorganization, perhaps in a Rac-dependent pathway (43).
and -
in a GTP-dependent manner, but the binding does
not seem to be direct. The interaction appears to be necessary for
Cdc42 and Ras to cause disassembly of stress fibers and could be
necessary for aPKC activation of p70S6 kinase.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
and PKC
and thus is referred to as the pan-aPKC
antibody. Glutathione S-transferase (GST) antibody was
purchased from Upstate Biotechnology, Inc. A monoclonal antibody
specific for the T7 peptide was purchased from Novagen. Secondary
antibody conjugates used for immunofluorescence were obtained from
Pierce and Boehringer Mannheim. Unstripped rat brains were obtained
from Pel Freez Biologicals. Cells were obtained from the American Type
Culture Collection, except for E1a/E1b-transformed 293 cells, which
were a gift from Yang Shi (Department of Pathology, Harvard Medical
School). PKC
was purified from baculovirus-infected insect cells as
described previously (27). All other reagents were obtained
from Sigma Chemical Co. unless otherwise stated.
and -
were
obtained from John Blenis and Angela Romanelli (Department of Cell
Biology, Harvard Medical School). A kinase-active form of PKC
was
made by mutation of alanine 120 to glutamate. A primer with the
mutation was used to obtain a fragment containing the mutation by PCR.
This fragment was cut with EcoNI and SgrAI and
ligated into the pCMV5 vector containing PKC
, which had been cut
with the same enzymes. A kinase-dead form of PKC
in pCMV5 was made
by ligating an EcoRI/AflII fragment from
kinase-dead PKC
in the SRD vector (S. Ohno, Department of Molecular
Biology, Yokohama City University School of Medicine, Yokohama, Japan)
into pCMV5 containing PKC
that had been cut with the same enzymes.
The T7 epitope-tagged regulatory domain of PKC
was made by removing
the AccI fragment from PKC
and pSKV3 (obtained from
Kiyotaka Nishikawa, Department of Cell Biology, Harvard Medical
School), which contains a 5' T7 sequence. The L61 Ras construct has
been previously described (4).
80°C. The proteins were active, as determined by their ability
to bind 3H-GTP in solution. The fusion proteins were loaded
with nucleotide by incubating them in a mixture of 20 mM HEPES (pH
7.5), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT with a 10-fold excess of
either GTP
S or GDP
S for 15 min at 30°C. MgCl2 was
then added to a final concentration of 5 mM, and incubations continued
for a further 10 min. Twenty-five microliters of a 50% slurry of GSH
beads was added as carrier to each incubation, and unbound nucleotide
was removed by washing the beads twice with 1 ml of HNM (20 mM HEPES [pH 7.5], 100 mM NaCl, 5 mM MgCl2).
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
S or
GDP
S and then incubated with rat brain homogenate. The beads were
washed and the proteins were separated by SDS-PAGE and transferred to
polyvinylidene fluoride membrane for Western blotting. As shown in Fig.
1, Cdc42 and, to a lesser extent, Rac
associated with aPKC in a GTP-dependent manner. Since the available
antibodies do not distinguish between PKC
and -
(data not shown),
we were not able to determine in these experiments which aPKC(s)
associated with Cdc42. Neither GST alone, RhoA, or Ras associated with
any PKC (the PKC
antibody also detects PKC
I and PKC
II; data
not shown). Ras has previously been reported to associate with aPKC
(10). An explanation for our failure to detect PKC
binding to Ras may be because full-length PKC
was reported to
associate poorly with Ras in vitro compared with the regulatory region
of PKC
. The interaction of RhoA with PKC
requires prenylation of
RhoA and so would not have been detected in this experiment
(7).

View larger version (27K):
[in a new window]
FIG. 1.
Cdc42 associates with aPKCs in rat brain cytosol. GST
alone or GST fusion proteins of RhoA, Rac1, Cdc42, or Ras, bound to
glutathione-Sepharose beads, were loaded with GTP
S or GDP
S and
then incubated with rat brain cytosol as described in Materials and
Methods. G protein-associated PKCs were detected by Western blotting
with PKC isoform-specific antibodies. These antibodies were also used
to immunoprecipitate PKC from rat brain cytosol, and these
immunoprecipitates are included as positive controls on the right side
of each blot. The GST fusion proteins were visualized by Western
blotting with a GST antibody.
Cdc42 associates with PKC
and -
in vivo.
To determine
whether Cdc42 associates with aPKCs in vivo, we transfected NIH 3T3
cells with GST-tagged Cdc42 mutants and PKC
or -
. We compared the
binding of aPKCs to the dominant-negative N17 mutant of Cdc42, which is
bound to GDP; the GTPase-deficient V12 mutant of Cdc42, which is bound
to GTP; and GST alone. Cell lysates were incubated with GSH beads, and
the associated proteins were analyzed by Western blotting with the aPKC
antibody. Endogenous aPKC associated with V12 Cdc42, but not with N17
Cdc42 or GST alone, in cells transfected only with Cdc42 constructs
(Fig. 2, lanes 1 to 3). There was a
marked increase in the amount of aPKC associated with V12 Cdc42 in
cells cotransfected with either PKC
or -
and Cdc42, indicating
that Cdc42 associates with both PKC
and -
in a GTP-dependent
manner (Fig. 2, lanes 4 to 9). The higher band in lanes 4 to 6 is
full-length PKC
, and the lower band is a proteolytic product. In
lanes 7 to 9, the upper band is full-length PKC
, and the lower band
is a proteolytic product.
|
The association between Cdc42 and aPKCs is likely indirect.
To
investigate whether Cdc42 associates directly with aPKCs, we incubated
bacterially expressed GST-Cdc42, bound to GSH beads and loaded with
GTP
S, with purified PKC
. PKC
was purified from insect cells
infected with a baculovirus expressing PKC
. We detected no binding,
as assessed by both kinase assays and Western blotting (data not
shown). Similarly, bacterially expressed GST fusions of either
full-length PKC
or of the regulatory domain of PKC
did not bind
to Cdc42, which had been expressed in bacteria, cleaved from GST, and
loaded with 3H-GTP (data not shown). We also detected no
signal when using Cdc42 loaded with [
-32P]GTP in a
far-Western blot for purified PKC
which had been separated by
SDS-PAGE and transferred to nitrocellulose paper (23). A control using the Wiskott-Aldridge syndrome protein gave a positive signal in this assay. Since we were unable to detect a direct interaction between Cdc42 and aPKCs by using multiple approaches, we
think it is likely that a third protein mediates the interaction of
aPKCs and Cdc42. We cannot rule out the possibility, however, that
aPKCs undergo a covalent modification in mammalian cells, which does
not occur in insect cells, that allows them to interact directly with
Cdc42. Since Cdc42 expressed in bacteria binds to aPKCs in cell
lysates, we do not think prenylation of Cdc42 is necessary for the interaction.
The effector region of Cdc42 and the regulatory domain of aPKC
mediate their association.
An effector region in the N terminus of
Rho family proteins mediates GTP-dependent binding to effector
molecules. Mutations in this region diminish or abolish the
GTP-dependent association with effector proteins (8, 18,
45). To confirm that the effector region of Cdc42 is necessary
for the interaction with aPKCs and to determine which region of the
effector region is necessary for the interaction, we transfected COS-7
cells with GST V12 Cdc42 containing additional mutations in the
effector region. Cell lysates were incubated with GSH beads, the beads were washed, and the association of endogenous aPKCs was determined by
Western blotting (Fig. 3A). As expected,
V12 Cdc42 bound well to aPKCs, wild-type Cdc42 bound less well, and
little binding was detected with N17 Cdc42. The V12/T35A mutant of V12
Cdc42 did not associate with aPKCs, whereas the V12/D38A mutant and, to
a lesser extent, the V12/Y40K mutant retained their ability to
associate with aPKC (Fig. 3A). The T35A mutant also fails to activate
p70S6 kinase (8).
|
and constructs expressing GST fusions of
N17 or V12 Cdc42. Cell lysates were incubated with GSH beads, and the
associated proteins were analyzed by Western blotting with the T7
antibody. As shown in Fig. 3B, the regulatory domain of PKC
associated with V12 Cdc42, but not N17 Cdc42, indicating that this
domain is sufficient for association with Cdc42. The regulatory domains
of PKC
and -
are highly homologous, so it is likely that the
regulatory domain of PKC
also mediates binding to Cdc42.
Cdc42 alone is not sufficient to activate aPKC.
Cdc42
activates other protein kinases with which it associates, and Rho1p
activates PKC1, so we determined whether Cdc42 activates aPKCs (8,
14, 48). NIH 3T3 cells were transfected with constructs
expressing Flag epitope-tagged PKC
and V12 Cdc42 or GST alone. The
activity of Flag-PKC
was assessed by in vitro kinase assay on Flag
immunoprecipitates with myelin basic protein as a substrate.
Cotransfection of V12 Cdc42 with Flag-PKC
failed to stimulate the
kinase activity of PKC
(Fig. 4A). The
slight increase in aPKC kinase activity in Flag immunoprecipitates from cells coexpressing V12 Cdc42 compared to those coexpressing the vector
is accounted for by the increased expression of the tagged aPKC in the
former cells (Fig. 4B). Similar results were obtained with PKC
(data
not shown). As a control, V12 Cdc42 stimulation of p70S6
kinase activity was assayed with S6 as a substrate. We also determined whether Cdc42 affected the kinase activity in the presence of phosphatidylserine, as reported for Rho1p and PKC1. Phosphatidylserine increased PKC
activity, as previously reported, but there was no
additional activation by Cdc42 (data not shown). Thus, in contrast to
the activation of other protein kinases with which it associates, Cdc42
alone does not activate aPKCs.
|
Cdc42 induces translocation of aPKC
from the nucleus to the
cytoplasm.
Since PKC
is primarily localized to the nucleus and
Cdc42 is a cytoplasmic protein, we thought that the interaction of
Cdc42 and PKC
might change the localization of one or both proteins (2). We transfected NIH 3T3 cells with epitope-tagged PKC
with either GST alone or with GST V12 Cdc42 and determined the localization of PKC
by indirect immunofluorescence. As previously reported, we found that PKC
was localized within the nuclei of transfected cells (Fig. 5A to C).
However, in cells cotransfected with V12 Cdc42, PKC
was found
primarily in the cytoplasm, where it colocalized with Cdc42 both in the
cytoplasm and at the cell periphery (Fig. 5D to F). PKC
is normally
cytoplasmic, and we did not detect a change in the location of PKC
when it was coexpressed with V12 Cdc42. The ability of the effector
region mutants of Cdc42 to induce nuclear to cytoplasmic translocation
correlated with their ability to bind Cdc42 (data not shown).
Relocalization of PKC
to the cytosol by Cdc42 provides further
evidence of the interaction in vivo and suggests that the function of
the complex is to localize PKC
. PKC
has been reported to move
from the nucleus to the cytosol in response to stimulation of cells
with EGF or PDGE, and our data suggest Cdc42 could function in this
pathway (2).
|
Cdc42 and PKC
induce the loss of stress fibers in NIH 3T3
cells.
To investigate the Cdc42 signaling pathway or pathways that
require aPKCs, we overexpressed the aPKCs to determine whether they
would activate Cdc42-dependent events. Since Cdc42 causes changes in
the actin cytoskeleton that lead to the formation of filopodia and the
loss of stress fibers, as well as ruffling due to Rac activation, we
determined whether overexpression of aPKCs similarly affects the actin
cytoskeleton. V12 Cdc42-induced loss of stress fibers in NIH 3T3 cells
(Fig. 6A and B and 7E), as has been
previously reported (17). Transient overexpression of
PKC
, but not of PKC
, induced the loss of stress fibers in NIH 3T3 cells (Fig. 6C to F). Cells expressing an activated form of PKC
also
lacked stress fibers (Fig. 6G and H). Although PKC
is primarily nuclear, the absolute amount of protein in the cytoplasm is likely to
be much higher in transfected cells due to overexpression. We propose
that it is this cytoplasmic fraction that mediates stress fiber loss. A
similar appearance of cells expressing activated PKC
was recently
reported (43). These results indicate that PKC
causes the
loss of stress fibers, but do not prove that it is necessary for
Cdc42-dependent loss of stress fibers.
|
Kinase-dead PKC
and -
block Cdc42-dependent loss of stress
fibers.
To determine if the effect of Cdc42 on stress fibers
requires aPKCs, we investigated whether kinase-dead forms of PKC
and -
would act as dominant negatives and inhibit Cdc42-induced changes in the actin cytoskeleton. NIH 3T3 cells were transfected with V12
Cdc42, and kinase-dead PKC
or -
and actin structures were examined. Stress fibers were present in about 75% of untransfected cells (Fig. 7E).
Expression of V12 Cdc42 resulted in
the loss of stress fibers in most cells (Fig. 6A and 7E), and
expression of kinase-dead PKC
or -
blocked Cdc42-induced loss of
stress fibers (Fig. 7A to E). Expression of kinase-dead PKC
or -
in the absence of V12 Cdc42 had no detectable effect on the actin cytoskeleton (data not shown). Expression of kinase-dead PKC
or -
did not affect the presence of filopodia or ruffles in cells also
expressing V12 Cdc42. We also investigated whether expression of
kinase-dead PKC
blocked the loss of stress fibers in cells expressing V12 Rac and found that it did not (Fig. 7F). These data
suggest that the effect of the kinase-dead aPKCs is specific to the
Cdc42 pathway regulating stress fibers and that they do not block all
Cdc42-dependent signaling. We also tested the ability of kinase-dead
forms of PKC
and -
to block Cdc42-dependent activation of JNK and
the FOS promoter and found no effect (data not shown), further
supporting the specificity of aPKCs for regulating Cdc42-dependent effects on stress fibers.
|
Ras-dependent loss of stress fibers requires Cdc42.
It was
recently reported that kinase-dead forms of PKC
and -
block
Ras-induced loss of stress fibers via a pathway requiring Rac
(43). Earlier work showed that dominant-negative N17 Cdc42, but not dominant-negative Rac, blocked Ras-induced cytoskeletal changes
(33). Our observations favor the model that Ras-induced loss
of stress fibers requires Cdc42 and its interaction with aPKCs. To test
this possibility, we first confirmed that transfection of activated L61
Ras results in the loss of stress fibers (Fig. 8B and
I).
We also found that kinase-dead
forms of PKC
and -
blocked Ras-induced loss of stress fibers
(Fig. 8C to F and I). To determine whether Ras-induced loss of stress
fibers was mediated by Cdc42, we cotransfected L61 Ras with
dominant-negative N17 Cdc42 and found that Ras-induced stress fiber
loss was blocked (Fig. 8G to I). We did not find an effect of
dominant-negative Rac on Ras-induced loss of stress fibers (Fig. 8J).
These observations suggest that the effect of Ras on stress fibers
requires Cdc42 and is likely mediated by the interaction of Cdc42 with
aPKCs.
|
| |
DISCUSSION |
|---|
|
|
|---|
The identification of proteins that associate with activated forms
of Rho family GTP-binding proteins has led to the discovery of many new
signaling pathways. We found that PKC
and -
associate with Cdc42
in a GTP-dependent manner and regulate the loss of stress fibers
induced by both Cdc42 and Ras. The regulatory domain of aPKCs is
sufficient to associate directly with Cdc42, and the effector region of
Cdc42 is required. aPKCs do not seem to associate directly with Cdc42,
indicating either that a covalent modification of aPKCs regulates
binding or that a third protein bridges the interaction. Expression of
activated Cdc42 results in the translocation of PKC
from the nucleus
to the cytoplasm and colocalization with Cdc42, but Cdc42 does not
appear to stimulate the kinase activity of aPKCs. These findings
suggest that the function of the association is to localize PKC
.
PKC
moves from the nucleus to the cytoplasm in response to
stimulation by platelet-derived growth factor and epidermal growth factor. This translocation requires phosphoinositide 3-kinase (PI
3-kinase) activity (2). Our data suggest a model in which growth factors activate PI 3-kinase, which in turn stimulates a Cdc42
GEF. Active Cdc42 associates with PKC
in the cytoplasm and localizes
it. Cdc42 may send signals that result in the translocation of PKC
,
or PKC
may move freely out of the nucleus, but association with
Cdc42 traps it in the cytoplasm and prevents nuclear import.
Fibroblasts expressing either the wild type or an activated mutant of
PKC
lack stress fibers, a phenotype previously described for
activated Cdc42 (17). Uberall et al. (43) found
that expression of constitutively active forms of either PKC
or
resulted in the absence of stress fibers, but we have not tested the
effects of an activated form of PKC
. There are several explanations
for the inability of overexpression of PKC
to cause loss of stress fibers. It is possible that only PKC
regulates stress fibers and
that an activated PKC
mimics the effects of PKC
or that both
PKC
and -
regulate stress fibers, but that wild-type PKC
is
less active than PKC
when overexpressed in vivo.
Kinase-dead forms of PKC
or -
block Cdc42-induced, but not
Rac-induced, loss of stress fibers, indicating that PKC
is
downstream of Cdc42 in regulating stress fibers. Kinase-dead forms of
PKC
and -
also block the loss of stress fibers in cells
expressing activated Ras (43). We confirmed that kinase-dead
forms of PKC
and -
blocked the effect of Ras on stress fibers and
found that a dominant-negative form of Cdc42, but not Rac, also blocked
Ras-induced loss of stress fibers. These data indicate that
Ras-stimulated loss of stress fibers depends on Cdc42 and its
association with PKC
.
Stress fibers are composed of bundled actin filaments that end in focal adhesions and are regulated by both contractility and inhibition of depolymerization of the pointed end of actin filaments. It is possible that the lack of stress fibers in cells expressing activated Cdc42 or Ras results from inhibition of RhoA activation, inhibition downstream of Rho, or activation of a separate pathway that blocks stress fiber formation. RhoA is necessary for Ras transformation, indicating that Ras likely activates RhoA. Thus, the inhibition of stress fiber formation by Ras, Cdc42, and aPKCs probably affects targets downstream of Rho that are not required for transformation by RhoA or Ras or stimulates a separate pathway (49).
Activation of RhoA and ROK leads to phosphorylation and activation of myosin light-chain kinase and inhibition of myosin light-chain phosphatase, resulting in an increase in myosin light-chain phosphorylation and contractility (16, 19). Both Rac and Cdc42 activate p21-associated kinase 1 (PAK1), which can inhibit myosin light-chain kinase and should lead to a reduction in contractility and stress fibers (39). Actin depolymerization is also regulated in part by cofilin. Phosphorylation of cofilin by LIM kinase inhibits its ability to depolymerize actin from the pointed end, leading to more prominent actin structures (3). One group found that ROK phosphorylates and activates LIM kinase, promoting stress fiber formation (22). However, other groups have found that Rac, but not Rho, activates LIM kinase (3, 46). Proteins in the pathways that regulate contractility and actin depolymerization downstream of Rho and ROK, such as myosin light-chain kinase and phosphatase and cofilin, are candidate targets for aPKCs, but the precise mechanism by which Cdc42 and aPKCs regulate stress fibers is not yet clear.
The interaction of Cdc42 with aPKCs could also be important in
transformation by Cdc42 and Ras. We have not yet investigated whether
kinase-dead forms of aPKCs block Cdc42-dependent transformation, but it
seems likely that they will, since Cdc42 is necessary for transformation by Ras and kinase-dead PKC
blocks Ras-dependent transformation (5, 49). Although Cdc42 itself can activate Rac, Cdc42 and Rac seem to function in separate pathways downstream of
Ras (17, 28, 33). Dominant-negative Cdc42 blocks Ras-induced changes in the actin cytoskeleton, but dominant-negative Rac does not.
Dominant-negative Rac, but not Cdc42, inhibits the growth of
Ras-transformed cells in low serum. Our data suggest that aPKCs function downstream of Cdc42 in Ras transformation to regulate stress
fibers. Uberall et al. (43) found that dominant-negative Rac
blocked Ras-induced cytoskeletal changes and placed PKC
upstream of
Rac, while we found no effect of dominant-negative Rac on
Ras-stimulated loss of stress fibers. Our findings are consistent with
the results of Qiu et al. (33), who found that
dominant-negative Cdc42, but not Rac, blocked Ras effects on the cytoskeleton.
The regulation of p70S6 kinase is complex and involves both
Rho family members and PKCs. p70S6 kinase is activated by
Cdc42 and associates with, and is activated by, PKC
and
(1,
8, 36). The A35 mutant of Cdc42 that fails to bind aPKCs also
fails to stimulate p70S6 kinase activity, and kinase-dead
PKC
partially blocks Cdc42-dependent activation of p70S6
kinase (36). Although it is not yet clear how a Cdc42-aPKC complex might function to activate p70S6 kinase, there is
correlative evidence suggesting that the complex could be important.
Cdc42 could function similarly to Ras in the activation of the
extracellular signal-regulated kinase pathway, as a component of a
multiprotein complex, which may localize and or activate protein kinases.
Kinase-dead forms of the aPKCs do not block other pathways that are
regulated by both Rho family proteins and PKCs, however. Both the JNK
pathway and the FOS promoter are activated by both Cdc42 and PKCs, but
we found no effect of kinase-dead PKC
or -
on Cdc42-induced JNK
activation or stimulation of the FOS promoter (7, 9, 15,
25). These results show that the kinase-dead forms of PKC
and
-
are specific and do not block all Cdc42-dependent signaling by
binding to the effector region. This specificity could be the result of
an indirect association of PKC
and -
with Cdc42, mediated by a
linker protein. If only a subset of active endogenous Cdc42
associates with the linker protein, then dominant-negative
aPKCs would inhibit signaling only of this fraction of Cdc42.
There are several candidate proteins that could mediate the interaction
of Cdc42 with the aPKCs, if the interaction is indirect. Both PAR-4 and
-interacting protein (ZIP) bind to the aPKC regulatory domain like
Cdc42 (11, 32). Interestingly, ZIP contains a short region
of homology with the Cdc42 GEFs and Scd1.
-interacting protein also
binds to the regulatory domain, but interacts only with PKC
and
therefore is unlikely to mediate the interaction, since Cdc42 also
binds to PKC
(12). Since none of these proteins has a
CRIB domain, it is possible that an unidentified protein bridges the
interaction between aPKCs and Cdc42. Identification of the factors that
regulate the association of aPKCs with Cdc42 and targets of the complex
will help contribute to our understanding of Cdc42 and aPKC signaling.
| |
ACKNOWLEDGMENTS |
|---|
We thank Anthony Couvillon, Judith Glaven, Paola Marignani,
Kimberley Tolias, Alex Toker, and Andrew Van Vugt for useful
discussions and critical reading of the manuscript. Additionally, we
are grateful to Alex Toker for purified PKC
and Angela Romanelli,
John Blenis, Shigeo Ohno, and Kiyotaka Nishikawa for PKC constructs.
This work was supported by NIH grant GM 54389 (C.L.C.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Signal Transduction, Harvard Institutes of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-5288. Fax: (617) 667-0957. E-mail: ccarpent{at}caregroup.harvard.edu.
Present address: SmithKline Beecham Pharmaceuticals, Harlow, Essex
CM19 5AW, United Kingdom.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akimoto, K., M. Nakaya, T. Yamanaka, J. Tanaka, S. Matsuda, Q. P. Weng, J. Avruch, and S. Ohno. 1998. Atypical protein kinase Clambda binds and regulates p70 S6 kinase. Biochem. J. 335:417-424. |
| 2. | Akimoto, K., R. Takahashi, S. Moriya, N. Nishioka, J. Takayanagi, K. Kimura, Y. Fukui, S. Osada, K. Mizuno, S. Hirai, A. Kazlauskas, and S. Ohno. 1996. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J. 15:788-798[Medline]. |
| 3. | Arber, S., F. A. Barbayannis, H. Hanser, C. Schneider, C. A. Stanyon, O. Bernard, and P. Caroni. 1998. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805-809[CrossRef][Medline]. |
| 4. |
Behre, G.,
A. J. Whitmarsh,
M. P. Coghlan,
T. Hoang,
C. L. Carpenter,
D. E. Zhang,
R. J. Davis, and D. G. Tenen.
1999.
c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.
J. Biol. Chem.
274:4939-4946 |
| 5. |
Bjorkoy, G.,
M. Perander,
A. Overvatn, and T. Johansen.
1997.
Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity.
J. Biol. Chem.
272:11557-11565 |
| 6. |
Burbelo, P. D.,
D. Drechsel, and A. Hall.
1995.
A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases.
J. Biol. Chem.
270:29071-29074 |
| 7. |
Chang, J.-H.,
J. C. Pratt,
S. Sawasdikosol,
R. Kapeller, and S. J. Burakoff.
1998.
The small GTP-binding protein Rho potentiates AP-1 transcription in T cells.
Mol. Cell. Biol.
18:4986-4993 |
| 8. | Chou, M. M., and J. Blenis. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573-583[CrossRef][Medline]. |
| 9. | Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-1146[CrossRef][Medline]. |
| 10. |
Diaz-Meco, M. T.,
J. Lozano,
M. M. Municio,
E. Berra,
S. Frutos,
L. Sanz, and J. Moscat.
1994.
Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta.
J. Biol. Chem.
269:31706-31710 |
| 11. | Diaz-Meco, M. T., M. M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz, and J. Moscat. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86:777-786[CrossRef][Medline]. |
| 12. |
Diaz-Meco, M. T.,
M. M. Municio,
P. Sanchez,
J. Lozano, and J. Moscat.
1996.
Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype / and stimulates its kinase activity in vitro and in vivo.
Mol. Cell. Biol.
16:105-114[Abstract].
|
| 13. | Gomez, J., A. Garcia, R.-B. L., P. Bonay, A. C. Martinez, A. Silva, M. Fresno, A. C. Carrera, C. Eicher-Streiber, and A. Rebollo. 1997. IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. J. Immunol. 158:1516-1522[Abstract]. |
| 14. |
Kamada, Y.,
H. Qadota,
C. P. Python,
Y. Anraku,
Y. Ohya, and D. E. Levin.
1996.
Activation of yeast protein kinase C by Rho1 GTPase.
J. Biol. Chem.
271:9193-9196 |
| 15. |
Kaneki, M.,
S. Kharbanda,
P. Pandey,
K. Yoshida,
M. Takekawa,
J.-R. Liou,
R. Stone, and D. Kufe.
1999.
Functional role for protein kinase C as a regulator of stress-activated protein kinase activation and monocytic differentiation of myeloid leukemia cells.
Mol. Cell. Biol.
19:461-470 |
| 16. | Kimura, K., M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamori, J. Feng, T. Nakano, K. Okawa, A. Iwamatsu, and K. Kaibuchi. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248[Abstract]. |
| 17. | Kozma, R., S. Ahmed, A. Best, and L. Lim. 1995. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol. Cell. Biol. 15:1942-1952[Abstract]. |
| 18. | Lamarche, N., N. Tapon, L. Stowers, P. D. Burbelo, P. Aspenstrom, T. Bridges, J. Chant, and A. Hall. 1996. Rac and Cdc42 induce actin polymerization and G1 cell cycle progression independently of p65PAK and the JNK/SAPK MAP kinase cascade. Cell 87:519-529[CrossRef][Medline]. |
| 19. |
Leung, T.,
X.-Q. Chen,
E. Manser, and L. Lim.
1996.
The p160 RhoA-binding kinase ROK is a member of a kinase family and is involved in the reorganization of the cytoskeleton.
Mol. Cell. Biol.
16:5313-5327[Abstract].
|
| 20. |
Lewis, J. M.,
D. A. Cheresh, and M. A. Schwartz.
1996.
Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation.
J. Cell. Biol.
134:1323-1332 |
| 21. |
Mackay, D. J., and A. Hall.
1998.
Rho GTPases.
J. Biol. Chem.
273:20685-20688 |
| 22. |
Maekawa, M.,
T. Ishizaki,
S. Boku,
N. Watanabe,
A. Fujita,
A. Iwamatsu,
T. Obinata,
K. Ohashi,
K. Mizuno, and S. Narumiya.
1999.
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.
Science
285:895-898 |
| 23. | Manser, E., T. Leung, H. Salihuddin, L. Tan, and L. Lim. 1993. A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 363:364-367[CrossRef][Medline]. |
| 24. | Manser, E., T. Leung, H. Salihuddin, Z. S. Zhao, and L. Lim. 1994. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367:40-46[CrossRef][Medline]. |
| 25. | Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157[CrossRef][Medline]. |
| 26. |
Newton, A. C.
1995.
Protein kinase C: structure, function, and regulation.
J. Biol. Chem.
270:28495-28498 |
| 27. |
Nishikawa, K.,
A. Toker,
F. J. Johannes,
Z. Songyang, and L. C. Cantley.
1997.
Determination of the specific substrate sequence motifs of protein kinase C isozymes.
J. Biol. Chem.
272:952-960 |
| 28. | Nobes, C. D., and A. Hall. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62[CrossRef][Medline]. |
| 29. | Nonaka, H., K. Tanaka, H. Hirano, T. Fujiwara, H. Kohno, M. Umikawa, A. Mino, and Y. Takai. 1995. A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae. EMBO J. 14:5931-5938[Medline]. |
| 30. |
Pietromonaco, S. F.,
P. C. Simons,
A. Altman, and L. Elias.
1998.
Protein kinase C-theta phosphorylation of moesin in the actin-binding sequence.
J. Biol. Chem.
273:7594-7603 |
| 31. | Price, L. S., J. Leng, M. A. Schwartz, and G. M. Bokoch. 1998. Activation of Rac and Cdc42 by integrins mediates cell spreading. Mol. Biol. Chem. 9:1863-1871. |
| 32. |
Puls, A.,
S. Schmidt,
F. Grawe, and S. Stabel.
1997.
Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein.
Proc. Natl. Acad. Sci. USA
94:6191-6196 |
| 33. | Qiu, R.-G., A. Abo, F. McCormick, and M. Symons. 1997. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell. Biol. 17:3449-3458[Abstract]. |
| 34. | Ridley, A. J., and A. Hall. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399[CrossRef][Medline]. |
| 35. | Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, and A. Hall. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410[CrossRef][Medline]. |
| 36. |
Romanelli, A.,
K. A. Martin,
A. Toker, and J. Blenis.
1999.
p70 S6 kinase is regulated by protein kinase C and participates in a phosphoinositide 3-kinase-regulated signalling complex.
Mol. Cell. Biol.
19:2921-2928 |
| 37. | Sahai, E., A. S. Alberts, and R. Treisman. 1998. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J. 17:1350-1361[CrossRef][Medline]. |
| 38. | Sahai, E., T. Ishizaki, S. Narumiya, and R. Treisman. 1999. Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9:136-145[CrossRef][Medline]. |
| 39. |
Sanders, L. C.,
F. Matsumura,
G. M. Bokoch, and P. de Lanerolle.
1999.
Inhibition of myosin light chain kinase by p21-activated kinase.
Science
283:2083-2085 |
| 40. |
Schlaepfer, D. D.,
K. C. Jones, and T. Hunter.
1998.
Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
Mol. Cell. Biol.
18:2571-2585 |
| 41. |
Tang, S.,
K. G. Morgan,
C. Parker, and J. A. Ware.
1997.
Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells.
J. Biol. Chem.
272:28704-28711 |
| 42. |
Tolias, K. F.,
L. C. Cantley, and C. L. Carpenter.
1995.
Rho family GTPases bind to phosphoinositide kinases.
J. Biol. Chem.
270:17656-17659 |
| 43. |
Uberall, F.,
K. Hellbert,
S. Kampfer,
K. Maly,
A. Villunger,
M. Spitaler,
J. Mwanjewe,
G. Baier-Bitterlich,
G. Baier, and H. H. Grunicke.
1999.
Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton.
J. Cell. Biol.
144:413-425 |
| 44. | Werlen, G., E. Jacinto, Y. Xia, and M. Karin. 1998. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101-3111[CrossRef][Medline]. |
| 45. | Westwick, J. K., Q. T. Lambert, G. J. Clark, M. Symons, L. Van Aelst, R. G. Pestell, and C. J. Der. 1997. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol. Cell. Biol. 17:1324-1335[Abstract]. |
| 46. | Yang, N., O. Higuchi, K. Ohashi, K. Nagata, A. Wada, K. Kangawa, E. Nishida, and K. Mizuno. 1998. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393:809-812[CrossRef][Medline]. |
| 47. |
Zeidman, R.,
B. Lofgren,
S. Pahlman, and C. Larsson.
1999.
PKCepsilon, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells.
J. Cell Biol.
145:713-726 |
| 48. |
Zhao, Z.-S.,
E. Manser,
X.-Q. Chen,
C. Chong,
T. Leung, and L. Lim.
1998.
A conserved negative regulatory region in PAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1.
Mol. Cell. Biol.
18:2153-2163 |
| 49. | Zohn, I. M., S. L. Campbell, R. Khosravi-Far, K. L. Rossman, and C. J. Der. 1998. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 17:1415-1438[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»